10-Q: Bowen Acquisition Corp Faces Delisting Amid Failed SPAC Merger
Quarterly Report
Bowen Acquisition Corp reports significant financial losses and a Nasdaq delisting decision after failing to complete its business combination with Qianzhi.
Summary
- Reported a net loss of $393,970 for the three months ended September 30, 2025, and $1,683,664 for the nine months ended September 30, 2025, a significant deterioration from prior year periods.
- Cash and cash equivalents significantly decreased to $17,731 as of September 30, 2025, from $103,774 at December 31, 2024.
- Investment held in the Trust Account plummeted to $8,215,231 as of September 30, 2025, from $75,794,241 at December 31, 2024, primarily due to substantial shareholder redemptions.
- The Company faces a Nasdaq delisting, with the decision affirmed on December 16, 2025, after failing to consummate its business combination by the October 15, 2025 deadline.
- Management has identified a material weakness in internal control over financial reporting due to a lack of qualified SEC reporting professionals.
- The proposed business combination with Shenzhen Qianzhi BioTechnology Co. Ltd. (Qianzhi) and Qianzhi Group Holding (Cayman) Limited (NewCo), approved by shareholders on January 14, 2025, remains pending regulatory approvals.
- Shareholder redemptions continued, with 54,475 Public Shares redeemed on December 12, 2025, further reducing the Trust Account to $7,660,670 and public shares to 673,396.
Sentiment
Score: 1
Explanation: StockSavvy.ai views this as highly negative due to significant financial deterioration, repeated delays in the business combination, substantial shareholder redemptions, and the confirmed Nasdaq delisting, all of which raise serious doubts about the Company's viability.
Positives
- Shareholders approved the business combination with Qianzhi on January 14, 2025.
- The S-4 Registration Statement for the business combination was declared effective on December 18, 2024.
- Management expects to obtain additional funds from related parties to provide necessary working capital to consummate a business combination.
Negatives
- Net loss of $393,970 for Q3 2025 and $1,683,664 for the nine months ended September 30, 2025, a significant deterioration from net income in the prior year periods.
- Substantial decrease in cash and cash equivalents to $17,731 and Trust Account balance to $8,215,231 as of September 30, 2025, due to high redemption rates.
- Working capital deficit of $2,418,171 as of September 30, 2025, indicating insufficient liquidity for ongoing operations.
- Nasdaq delisting decision affirmed on December 16, 2025, due to failure to complete the business combination by the extended deadline of October 15, 2025.
- Identified a material weakness in internal control over financial reporting due to a lack of qualified SEC reporting professionals.
- Incurred a $1,929,656 loss on the issuance of FPA liability for the nine months ended September 30, 2025.
Risks
- Substantial doubt about the Company's ability to continue as a going concern due to limited cash, significant working capital deficit, and the risk of liquidation if the business combination is not completed.
- Failure to complete the business combination within the Combination Period could lead to liquidation and dissolution, extinguishing public shareholders' rights.
- Nasdaq delisting of the Company's securities, effective November 3, 2025, due to failure to meet listing requirements and complete the business combination by the specified deadline.
- Material weakness in internal control over financial reporting related to the lack of qualified SEC reporting professionals, which could affect the accuracy of financial reporting.
- Dependence on related parties for additional funds to cover working capital deficiencies and transaction costs.
- Uncertainty regarding regulatory approvals for the proposed business combination with Qianzhi.
- High redemption rates by public shareholders, significantly depleting the Trust Account and reducing the capital available for the business combination.
Future Outlook
The Company's proposed business combination with Qianzhi remains pending, awaiting required regulatory approvals, despite shareholder approval on January 14, 2025. Management expects to obtain additional funds from related parties to provide the necessary working capital to consummate the business combination. However, the Company faces substantial doubt about its ability to continue as a going concern and has received a final delisting decision from Nasdaq.
Management Comments
- Management believes that these conditions raise substantial doubt about the Company's ability to continue as a going concern.
- Management expects to obtain additional funds from related parties to provide the additional working capital necessary to carry out its objective to consummate a business combination.
- Our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures... were not effective due solely to the material weakness in our internal control over financial reporting related to the Company's lack of qualified SEC reporting professional.
- Management intends to continue implement remediation steps to improve our disclosure controls and procedures and our internal control over financial reporting.
Industry Context
StockSavvy.ai notes that the SPAC market has seen increased scrutiny and higher redemption rates in recent periods, making it challenging for SPACs like Bowen Acquisition Corp to complete their initial business combinations. The significant redemptions and subsequent delisting highlight the difficulties faced by SPACs that fail to secure and close a target acquisition within their mandated timelines, often leading to liquidation or delisting. The ongoing struggle to secure regulatory approvals for the Qianzhi merger, coupled with dwindling trust account funds, is indicative of broader market headwinds for SPACs, particularly those with international targets.
Comparison to Industry Standards
- The high redemption rates experienced by Bowen Acquisition Corp, leading to a drastic reduction in its Trust Account from $75.8 million to $8.2 million (and further to $7.7 million post-Q3), are significantly worse than the industry average for successful SPACs, which typically aim for lower redemption rates to preserve capital for the de-SPAC transaction. For example, successful SPACs like Gores Holdings VI (acquiring Ardagh Metal Packaging) or Churchill Capital Corp IV (acquiring Lucid Motors) saw lower initial redemption rates or were able to secure PIPE investments to offset redemptions, maintaining substantial trust balances.
- The failure to complete the business combination by the Nasdaq-imposed deadline of October 15, 2025, and the subsequent delisting, places Bowen Acquisition Corp in a category of unsuccessful SPACs. In contrast, SPACs that successfully complete mergers, such as those that brought DraftKings or Virgin Galactic public, navigated regulatory hurdles and investor sentiment effectively to maintain their listing status.
- The identified material weakness in internal control over financial reporting, specifically the lack of qualified SEC reporting professionals, falls below the standard expected of publicly traded companies, including SPACs, which are required to maintain robust financial reporting controls.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Internal Control Weakness | Identified a material weakness in internal control over financial reporting due to the Company's lack of qualified SEC reporting professional. | 2025-09-30 | Could adversely affect the Company's ability to record, process, summarize, and report financial information accurately. |
Related Party Transactions
- Promissory note from EBC (one of the Sponsors) for $500,000, outstanding as of September 30, 2025, bearing no interest and repayable upon business combination.
- Accrued expenses due to related parties totaling $207,556 as of September 30, 2025, including $180,000 for administration fees and $27,556 for accounting-related and other service fees.
- Accounting service agreement with TenX Global Capital (a related party) at a fixed quarterly rate of $5,250.
- Administration fee of up to $10,000 per month charged by an affiliate of the Sponsors for office, utilities, and personnel.
- One of the Sponsors transferred 30,000 Founder Shares to EBC in connection with the $500,000 loan.
Stakeholder Impact
- Shareholders: Public shareholders have experienced significant redemptions, reducing their ownership and the Trust Account value. The delisting will severely impact liquidity and potentially the value of remaining shares. Holders of rights will not receive any funds for their rights if the Company liquidates.
- Employees: Not directly mentioned, but the ongoing uncertainty and potential liquidation could impact future employment.
- Customers: Not applicable as a blank check company.
- Suppliers: Not directly mentioned, but the Company's financial difficulties could impact its ability to pay service providers.
- Creditors: Related party lenders (Sponsors, EBC) are exposed to the risk of the business combination not closing, as their loans are repayable upon consummation.
Next Steps
- Obtain additional funds from related parties to provide necessary working capital.
- Continue efforts to complete the business combination with Qianzhi, pending regulatory approvals.
- Implement remediation steps to improve disclosure controls and procedures and internal control over financial reporting, including enhancing access to accounting literature, consulting third-party professionals, and considering additional staff.
- The Company's securities are expected to be delisted from Nasdaq.
Key Dates
| Date | Description |
|---|---|
| 2023-02-17 | Company incorporated in the Cayman Islands. |
| 2023-07-11 | Registration statement for the Company's IPO declared effective. |
| 2023-07-14 | Initial Public Offering (IPO) consummated, selling 6,000,000 units at $10.00 per unit. |
| 2023-07-17 | Underwriters exercised their over-allotment option in full. |
| 2023-07-18 | Company sold an additional 900,000 units due to over-allotment exercise. |
| 2023-11-20 | Bowen Merger Sub, a wholly-owned subsidiary, was formed. |
| 2024-01-18 | Entered into an Agreement and Plan of Reorganization with Bowen Merger Sub, Shenzhen Qianzhi BioTechnology Co. Ltd., and Qianzhi Group Holding (Cayman) Limited. |
| 2024-10-07 | Notified trustee of Trust Account of extension to consummate initial Business Combination from October 14, 2024, to January 14, 2025. |
| 2024-10-14 | Shenzhen Qianzhi and EBC loaned the Company an aggregate of $690,000 for the extension, deposited into the Trust Account. |
| 2024-12-18 | Company's Registration Statement on Form S-4 declared effective. |
| 2025-01-10 | Extraordinary general meeting held to approve an amendment to extend the business combination deadline; 6,052,095 Public Shares redeemed. |
| 2025-01-13 | Entered into a Prepaid Forward Purchase Agreement (FPA) with Harraden Circle Investments, LLC. |
| 2025-01-14 | Extraordinary general meeting held to approve the business combination with Qianzhi; all proposals approved by shareholders. |
| 2025-04-14 | Extraordinary general meeting held to approve an extension of the business combination deadline to July 14, 2025; 103,432 Public Shares redeemed. |
| 2025-07-11 | Extraordinary general meeting held to approve an extension of the business combination deadline to December 14, 2025; 16,602 Public Shares redeemed. |
| 2025-08-21 | Nasdaq Hearings Panel hearing on delisting matter held. |
| 2025-09-04 | Nasdaq Hearings Panel granted request to continue listing conditional on consummating business combination by October 15, 2025. |
| 2025-09-30 | End of the quarterly reporting period. |
| 2025-10-15 | Deadline set by Nasdaq for consummating the business combination (missed). |
| 2025-10-30 | Received Nasdaq delisting notification due to failure to meet the October 15, 2025 deadline. |
| 2025-11-03 | Effective date for Nasdaq delisting (unless appealed). |
| 2025-12-12 | Extraordinary general meeting held to approve an extension of the business combination deadline to June 14, 2026; 54,475 Public Shares redeemed. |
| 2025-12-16 | Nasdaq Listing and Hearing Review Council affirmed the Panel's decision to delist the Company. |
| 2026-02-05 | Date of filing of the Form 10-Q. |
Recommendation
strong sellThe Company faces imminent delisting from Nasdaq, has experienced massive shareholder redemptions, reported significant net losses, and operates with a substantial working capital deficit, raising serious going concern doubts. The proposed business combination remains stalled due to regulatory approvals, and the financial position has deteriorated severely. These factors indicate a high probability of further value erosion and potential liquidation, making it an extremely high-risk investment.
Keywords
SPAC, Bowen Acquisition Corp, BOWN, 10-Q, Quarterly Report, Business Combination, Qianzhi, Delisting, Nasdaq, Redemptions, Going Concern, Financial Results, Trust Account, Forward Purchase Agreement, Internal Controls, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.